Effect of Cognition Recovery by Repetitive Transcranial Magnetic Stimulation on Ipsilesional Dorsolateral Prefrontal Cortex in Subacute Stroke Patients

Abstract

ObjectiveTo demonstrate the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the ipsilesional dorsolateral prefrontal cortex (DLPFC) on neurological recovery in patients with subacute phase stroke.MethodsPatients with supratentorial hemispheric stroke who were hospitalized for intensive rehabilitation in the subacute phase were enrolled for this retrospective analysis. Two groups of patients were selected: the rTMS group who received high-frequency (20 Hz) rTMS ≥ 5 times over the ipsilesional DLPFC, and a control group who did not receive any rTMS. The patients were further divided into groups with right- or left-side brain lesions. Functional measurements for cognitive ability, mood, speech, and activities of daily living, which were assessed at baseline and at the 1-month follow-up as a routine clinical practice, were used for analyses.ResultsAmong 270 patients with available clinical data, 133 (women, 51; age, 61.0 ± 13.8 years) met the inclusion criteria and were enrolled for analysis. There were no differences in demographic data and functional scores at baseline between the rTMS (n = 49) and control (n = 84) groups. The rTMS group showed a higher gain in the mini-mental status examination (MMSE) total score and subscores of all domains, forward digit span, and FIM-cognition than the control group (P < 0.05). Among the patients with left hemispheric lesions (n = 57), the rTMS group showed better outcomes in cognition and depression through scores of total and “attention and concentration” subscores of MMSE, FIM-cognition, and the geriatric depression scale (P < 0.05). Among the patients with right hemispheric lesions (n = 76), the rTMS group showed better outcomes in cognition through the MMSE total score and subscores of “attention and concentration,” “registration,” and “recall,” and scores of both forward and backward digit spans (P < 0.05).ConclusionHigh-frequency rTMS over the ipsilesional DLPFC has beneficial effects on the recovery of cognition on both sides as well as mood in patients with left-sided hemispheric lesions.

Effectiveness Evaluation of Repetitive Transcranial Magnetic Stimulation Therapy Combined with Mindfulness-Based Stress Reduction for People with Post-Stroke Depression: A Randomized Controlled Trial

“…The significant improvement in cognitive function is in line with that reported by Kim et al [46] in their retrospective study at the rehabilitation center of a universityaffiliated general hospital and Zou et al [22] in their "A Systematic Review with Meta-Analysis". They found a high gain in the MMSE total score and sub-scores of all domains, including attention and concentration, registration, and recall.…”

Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation for Post-stroke Vascular Cognitive Impairment: A Prospective Pilot Study

“…Nevertheless, there is no definitive protocol for the use of rTMS to enhance cognition in post-stroke patients ( 20 ). Our clinical research team established a treatment protocol with high-frequency rTMS over the ipsilesional DLPFC according to our clinical experiences with positive results by retrospective analyses ( 21 ). In this study, we aimed to determine whether high-frequency rTMS on the ipsilesional DLPFC had a therapeutic effect in patients with PSCI during the chronic phase of stroke who also exhibited depressive symptoms.…”

Effects of scalp acupuncture combined with repetitive transcranial magnetic stimulation on post-stroke cognitive impairment at different time intervals

“…Scalp acupuncture as a treatment modality adjusts the overall qi and blood of the viscera and meridians to alleviate mental and physical symptoms, restoring them to normalcy. Previous research has shown that scalp Am J Transl Res 2024; 16(2):592-598 acupuncture combined with rTMS can improve cognitive impairment in stroke patients and the effect of rTMS lasted up to 18-week follow-up [4][5][6][7]. But complications or environmental reasons can hinder patients from receiving prompt and appropriate cognitive care.…”